Insulet Corporation (PODD) vs Smith & Nephew SNATS, Inc. (SNN)
Insulet Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $11.2B against $9.6B — 1.2× the size. Insulet Corporation trades at the lower P/E: 25.4× against 32.8×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 4.81%. Insulet Corporation has the higher net margin (12.3% vs 6.71%) and the higher return on invested capital (17.6% vs 0.00%). Across the 22 metrics below, Insulet Corporation leads on 14 and Smith & Nephew SNATS, Inc. on 8.
Valuation
Profitability
| Metric | PODD | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.07% | 70.52% | 56.01% |
| Operating margin | 16.89% | 0.00% | (15.03%) |
| Net margin | 12.29% | 6.71% | (20.40%) |
| Free cash flow margin | 8.70% | 0.00% | (7.24%) |
| Return on equity | 26.02% | 0.00% | (15.32%) |
| Return on assets | 11.31% | 0.00% | (19.72%) |
| Return on invested capital | 17.56% | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack